WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

WW International, Inc. (NASDAQ:WW – Get Free Report) was the target of unusually large options trading on Wednesday. Traders purchased 17,056 call options on the company. This is an increase of 1,502% ...

Analysts maintain a pessimistic view of WeightWatchers parent company WW International ($WW) despite investors new found ...

A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...

WW International (WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the company's ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Stephanie Davis, an analyst from Barclays, maintained the Sell rating on WW International (WW – Research Report). The associated price ...

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...

WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

On Monday, WW International Inc (WW) stock saw a modest uptick, ending the day at $0.88 which represents a slight increase of $0.05 or 6.02% from the prior close of $0.83. The stock opened at $0.82 ...

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.